Daniel Joseph McCarthy bought $99k of EVH
PRESIDENT at Evolent Health, Inc.. 11,040 shares at an average of $9.01, traded Mar 6, 2025, filed Mar 10, 2025.
Score components
- +20RolePresident
- +10Trade size$99k at market
- 0Relative to holdingsHoldings up 2.9%
- 0Price contextNo price history yet
- +15Cluster9 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628908-25-000050, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 6, 2025 | POpen-market purchase Class A Common Stock | +11,040 | $9.01 | $99k | 389,004 | Mar 10, 2025 |
Related signals
Other insiders at Evolent Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Evolent Health, Inc. | Craig A. Barbarosh director | $18k 2,000 shares | +7% | |
| 61Notable | Evolent Health, Inc. | Seth Blackley Chief Executive Officer | $498k 55,225 shares | +8% | |
| 46Moderate | Evolent Health, Inc. | Kim Keck director | $99k 10,540 shares | +36% | |
| 47Moderate | Evolent Health, Inc. | Russell Monroe Glass director | $50k 5,400 shares | +61% | |
| 56Moderate | Evolent Health, Inc. | Brendan B Springstubb director | $139k 15,000 shares | +127% | |
| 50Moderate | Evolent Health, Inc. | Peter J Grua director | $99k 11,040 shares | +143% | |
| 51Moderate | Evolent Health, Inc. | Richard M Jelinek director | $274k 30,000 shares | - | |
| 35Weak | Evolent Health, Inc. | Diane Holder director | $26k 2,735 shares | +4% | |
| 46Moderate | Evolent Health, Inc. | Brendan B Springstubb director | $44k 5,000 shares | +73% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.